Basel Medical Group Ltd announced it has regained compliance with Nasdaq's minimum bid price rule after its share price stayed at or above $1.00 for 10 consecutive business days ending July 7, 2026. The company was previously notified in January 2026 for failing to maintain this minimum price. Regaining compliance allows Basel Medical to maintain its Nasdaq listing, supporting its position as a leading healthcare provider in Singapore. The company continues to benefit from growth opportunities in the private healthcare sector across Southeast Asia.
July's Consumer Price Index (CPI) eased to 3.4%, signaling slower overall inflation. However, the insurance sector faces mixed impacts: motor vehicle insurance prices fell 4.5% year-over-year, yet maintenance and repair costs rose 6.6%, widening the ...
Tesla shares rose 4.2% last week, buoyed by strong vehicle sales in China, record global deliveries in Q2 2026, and the end of a Swedish union strike. Key growth drivers include expanding energy projects, autonomous ride-hailing services, and AI deve...
Broadcom reported $22.2 billion in quarterly revenue, with $10.8 billion from AI chips, showing a 143% year-on-year growth and projecting over $100 billion AI revenue by 2027. Marvell posted $2.418 billion, focusing on data center chips, with plans t...
Applied Optoelectronics (AAOI) projects over 170% year-over-year revenue growth by 2027, driven by strong demand for high-speed optical transceivers like 800G and 1.6T products. The company expects 2026 revenue to reach about $1.1 billion, with produ...
USANA Health Sciences introduced Clear Protein + Creatine Mix, a new drink combining 10 grams of protein, 5 grams of creatine, and over 600 mg of electrolytes in just 50 calories. This product simplifies nutrition for active adults by merging three c...
